Fort Point Capital Partners LLC Eli Lilly & CO Transaction History

Fort Point Capital Partners LLC

$749 Million
Q1 2024

A detailed history of Fort Point Capital Partners LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Fort Point Capital Partners LLC holds 2,493 shares of LLY stock, worth $2.26 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

2,493

Previous 2,503 0.4%

Holding current value

$2.26 Million

Previous $1.46 Million 32.9%

% of portfolio

0.26%

Previous 0.21%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $5,922 - $7,922	-10 Reduced 0.4%	2,493 $1.94 Million
Q4 2023 Feb 09, 2024	BUY	$525.19 - $619.13 $2,625 - $3,095	5 Added 0.2%	2,503 $1.46 Million
Q3 2023 Nov 08, 2023	BUY	$434.7 - $599.3 $81,288 - $112,069	187 Added 8.09%	2,498 $1.34 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $19,290 - $25,793	55 Added 2.44%	2,311 $1.08 Million
Q1 2023 May 11, 2023	BUY	$310.63 - $364.82 $7,765 - $9,120	25 Added 1.12%	2,256 $774,000

Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $8,681 - $10,116	-27 Reduced 1.2%	2,231 $816,000
Q3 2022 Nov 09, 2022	SELL	$296.48 - $337.87 $592 - $675	-2 Reduced 0.09%	2,258 $730,000
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $35,119 - $41,236	-126 Reduced 5.28%	2,260 $733,000
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $29,336 - $36,457	125 Added 5.53%	2,386 $683,000
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $1,124 - $1,395	-5 Reduced 0.22%	2,261 $625,000
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $142,045 - $174,807	641 Added 39.45%	2,266 $524,000
Q2 2021 Jul 30, 2021	BUY	$180.55 - $233.54 $180 - $233	1 Added 0.06%	1,625 $373,000
Q1 2021 May 10, 2021	SELL	$164.32 - $212.72 $49,296 - $63,816	-300 Reduced 15.59%	1,624 $303,000
Q4 2020 Feb 09, 2021	SELL	$130.46 - $172.63 $28,701 - $37,978	-220 Reduced 10.26%	1,924 $325,000
Q3 2020 Nov 10, 2020	BUY	$146.22 - $169.13 $21,055 - $24,354	144 Added 7.2%	2,144 $317,000
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $5,456 - $6,567	-40 Reduced 1.96%	2,000 $328,000
Q1 2020 May 14, 2020	BUY	$119.05 - $147.35 $11,905 - $14,735	100 Added 5.15%	2,040 $283,000
Q4 2019 Feb 03, 2020	BUY	$106.92 - $132.43 $207,424 - $256,914	1,940 New	1,940 $255,000
Q2 2019 Aug 09, 2019	SELL	$110.79 - $129.32 $173,718 - $202,773	-1,568 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$111.31 - $131.02 $110,753 - $130,364	-995 Reduced 38.82%	1,568 $203,000
Q4 2018 Feb 11, 2019	BUY	$105.9 - $118.64 $2,965 - $3,321	28 Added 1.1%	2,563 $297,000
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $48,596 - $60,737	-566 Reduced 18.25%	2,535 $272,000
Q2 2018 Aug 13, 2018	SELL	$75.7 - $86.88 $17,032 - $19,548	-225 Reduced 6.76%	3,101 $265,000
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $46,084 - $54,399	-621 Reduced 15.73%	3,326 $257,000
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $323,417 - $346,901	3,947	3,947 $333,000

Others Institutions Holding LLY

# of Institutions

3,719

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $860B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Point Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fort Point Capital Partners LLC with notifications on news.

Account

Fort Point Capital Partners LLC Eli Lilly & CO Transaction History